In line with this finding, SALL4 is highly expressed in cisplatin-resistant lung cancer cells and knock down of this gene improves response to cisplatin treatment by induction of apoptosis through AKT/mTOR signaling pathways [84]. The gene discussed is SALL4; the disease is lung carcinoma.